Puvanesarajah Varun, Cancienne Jourdan M, Shimer Adam L, Shen Francis H, Hassanzadeh Hamid
Department of Orthopaedic Surgery, Johns Hopkins Hospital, Baltimore, Maryland, United States.
Department of Orthopaedic Surgery, University of Virginia, Charlottesville, Virginia, United States.
Global Spine J. 2017 Feb;7(1):28-32. doi: 10.1055/s-0036-1583175. Epub 2017 Feb 1.
Retrospective analysis of a Medicare database (2005 to 2012).
To study postoperative complication rates following thoracolumbar fusion for traumatic thoracolumbar fracture in patients with ankylosing spondylitis (AS) compared with patients without AS.
The PearlDiver database (2005 to 2012) was queried to examine postoperative complication rates in patients with AS undergoing posterior thoracolumbar fusion for thoracolumbar fracture ( = 968). Complication rates were compared with proportion-matched controls without AS undergoing the same procedure ( = 1,979). We examined and compared the incidence of death, postoperative infection, transfusion, venous thromboembolism, respiratory failure, pneumonia, myocardial infarction, urinary tract infection, and acute renal failure in each cohort within 90 days postoperatively.
Patients with AS had significantly higher rates of surgical site infection (odds ratio [OR] 1.6, 95% confidence interval [CI] 1.2 to 2.2, = 0.002), day-of-surgery transfusion rates (OR 1.5, 95% CI 1.3 to 1.8, < 0.0001), respiratory failure (OR 1.8, 95% CI 1.3 to 2.5, = 0.0006), pneumonia (OR 1.8, 95% CI 1.3 to 2.5, = 0.0002), acute renal failure (OR 1.6, 95% CI 1.2 to 2.3, = 0.005), and total medical complications (OR 1.5, 95% CI 1.2 to 1.9, < 0.0001). Ninety-day mortality was not different between the two cohorts ( = 0.18).
Thoracolumbar fusion for thoracolumbar fracture in patients with AS is associated with increased rates of surgical site infection, transfusion, respiratory failure, pneumonia, and acute renal failure postoperatively compared with patients without AS. The level of evidence in this study was III.
对医疗保险数据库(2005年至2012年)进行回顾性分析。
研究强直性脊柱炎(AS)患者与非AS患者因创伤性胸腰椎骨折行胸腰椎融合术后的并发症发生率。
查询PearlDiver数据库(2005年至2012年),以检查因胸腰椎骨折接受后路胸腰椎融合术的AS患者(n = 968)的术后并发症发生率。将并发症发生率与接受相同手术的非AS比例匹配对照组(n = 1,979)进行比较。我们检查并比较了每个队列术后90天内死亡、术后感染、输血、静脉血栓栓塞、呼吸衰竭、肺炎、心肌梗死、尿路感染和急性肾衰竭的发生率。
AS患者的手术部位感染率(优势比[OR] 1.6,95%置信区间[CI] 1.2至2.2,P = 0.002)、手术当天输血率(OR 1.5,95% CI 1.3至1.8,P < 0.0001)、呼吸衰竭(OR 1.8,95% CI 1.3至2.5,P = 0.0006)、肺炎(OR 1.8,95% CI 1.3至2.5,P = 0.0002)、急性肾衰竭(OR 1.6,{95% CI 1.2至2.3},P = 0.005)和总医疗并发症(OR 1.5,95% CI 1.2至1.9,P < 0.0001)显著更高。两个队列的90天死亡率无差异(P = 0.18)。
与非AS患者相比,AS患者因胸腰椎骨折行胸腰椎融合术后手术部位感染、输血、呼吸衰竭、肺炎和急性肾衰竭的发生率增加。本研究的证据水平为III级。